Holen Sie sich die Stockscreener-App
71.42
2.43%
-1.78
Handel nachbörslich:
71.53
0.11
+0.15%
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Investors Can Find Comfort In Solventum's (NYSE:SOLV) Earnings Quality - ca.finance.yahoo.com
Charting the Course: Solventum Corp’s SOLV Stock Prospects - investchronicle.com
MediWound Revenue Jumps 43% in Q2 - The Motley Fool
3M Company shares fall 1.46% intraday after secondary offering of Solventum and Neogen Corporation lawsuit. - AInvest
Solventum prices 8.8M share secondary offering - MSN
Historical volatility pattern of Solventum Corporation visualized2025 Bull vs Bear & High Accuracy Trade Signal Alerts - Newser
Solventum's Secondary Offering: A Strategic Move to Accelerate AI-Driven Healthcare IT Growth - AInvest
3M Prices $648 Million Secondary Offering of Solventum Shares - MarketScreener
How Investors Are Reacting To Solventum (SOLV) Raising 2025 Guidance After Solid Q2 Results - simplywall.st
Stock Analysis | Solventum OutlookA Tumultuous Crossroads in a Volatile Market - AInvest
Solventum's Secondary Offering: Balancing Shareholder Value and Healthcare IT Innovation - AInvest
5 Insightful Analyst Questions From Solventum’s Q2 Earnings Call - Yahoo Finance
Solventum Announces Pricing Of Secondary Offering Of 8.80 Mln Common Stock - Nasdaq
Solventum Announces Pricing of Secondary Offering of Common Stock to Raise Approximately $648 Million - AInvest
3M to sell Solventum shares for $648 million in secondary offering - Investing.com
Solventum Announces Pricing of Secondary Offering of Common Stock - PR Newswire
Solventum announces launch of secondary offering of common stock - MSN
Solventum Announces Secondary Offering of 8.8 Million Shares by 3M - MarketScreener
Solventum stock falls after 3M announces secondary offering By Investing.com - Investing.com Nigeria
Solventum's Secondary Offering: A Balancing Act Between Liquidity and Dilution - AInvest
Solventum stock falls after 3M announces secondary offering - Investing.com
3M to sell 8.8 million shares of Solventum in secondary offering - Investing.com
3M to sell 8.8 million shares of Solventum in secondary offering By Investing.com - Investing.com South Africa
Solventum Announces Launch of Secondary Offering of Common Stock - PR Newswire
Solventum Corporation (NYSE:SOLV) Stock Position Lowered by LPL Financial LLC - Defense World
Solventum Corporation (SOLV) Reports Q2 2025 Results; Mizuho and Wells Fargo Reiterate Their Ratings - Yahoo Finance
Will Solventum Corporation see short term momentumFree Reliable Alerts for Daily Stock Movers - Newser
Solventum ups financial guidance as tariff risks fade - MSN
Steris, Solventum upgraded, RxSight downgraded in Morgan Stanley's MedTech review - MSN
How Is Solventum's Stock Performance Compared to Other Health Care Equipment Stocks? - MSN
Research Alert: CFRA Maintains Hold Opinion On Shares Of Solventum Corporation - 富途牛牛
Solventum Announces Launch Of Secondary Offering Of Common Stock - Barchart.com
Federated Hermes Inc. Trims Stock Position in Solventum Corporation (NYSE:SOLV) - Defense World
Will Strong Q2 Results and Raised Outlook Change Solventum's (SOLV) Narrative? - simplywall.st
Piper Sandler Forecasts Strong Price Appreciation for Solventum (NYSE:SOLV) Stock - Defense World
Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Solventum raises annual profit forecast on strength in surgical equipment - MSN
Analysts Offer Insights on NA Companies: GE Vernova Inc. (GEV) and Solventum Corporation (SOLV) - The Globe and Mail
Piper Sandler Boosts Solventum (NYSE:SOLV) Price Target to $94.00 - MarketBeat
Should Solventum's (SOLV) Earnings Upgrade and Revenue Growth Prompt Portfolio Reassessment by Investors? - simplywall.st
Solventum 2025 Q2 Earnings Net Income Rises 1.1% - AInvest
Solventum Q2 FY25 slides reveal improved performance and increased full-year outlook - Investing.com Canada
Solventum Exceeds 2Q25 Expectations with $2.16B Revenue, Reduces Tariff Impact - Medical Device and Diagnostic industry
Goldman Sachs Adjusts Solventum Price Target to $73 From $71, Maintains Sell Rating - MarketScreener
Solventum Stock Gains on Q2 Earnings & Revenue Beat, Margins Improve - The Globe and Mail
Solventum Stock Gains On Q2 Earnings & Revenue Beat, Margins Improve - Barchart.com
Solventum raises 2025 EPS guidance to $5.80-$5.95 with sales growth outlook up to 3% as transformation gains momentum - MSN
Solventum Boosts Annual Profit Outlook on Surging Medical Device DemandNews and Statistics - IndexBox
Solventum (SOLV) Beats Q2 Earnings and Revenue Estimates - NewsBreak: Local News & Alerts
Solventum stock price target raised to $94 by Piper Sandler on strong Q2 - Investing.com Nigeria
Solventum price target raised to $94 from $87 at Piper Sandler - TipRanks
Solventum rises after lifting annual profit forecast - TradingView
1.10%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):